Literature DB >> 12176984

Identification and characterization of the interaction between tuberin and 14-3-3zeta.

Mark Nellist1, Miriam A Goedbloed, Christa de Winter, Brenda Verhaaf, Anita Jankie, Arnold J J Reuser, Ans M W van den Ouweland, Peter van der Sluijs, Dicky J J Halley.   

Abstract

Tuberous sclerosis is caused by mutations to either the TSC1 or TSC2 tumor suppressor gene. The disease is characterized by a broad phenotypic spectrum that includes seizures, mental retardation, renal dysfunction, and dermatological abnormalities. TSC1 encodes a 130-kDa protein called hamartin, and TSC2 encodes a 200-kDa protein called tuberin. Although it has been shown that hamartin and tuberin form a complex and mediate phosphoinositide 3-kinase/Akt-dependent phosphorylation of the ribosomal protein S6, it is not yet clear how inactivation of either protein leads to tuberous sclerosis. Therefore, to obtain additional insight into tuberin and hamartin function, yeast two-hybrid screening experiments were performed to identify proteins that interact with tuberin. One of the proteins identified was 14-3-3zeta, a member of the 14-3-3 protein family. The interaction between tuberin and 14-3-3zeta was confirmed in vitro and by co-immunoprecipitation; multiple sites within tuberin for 14-3-3zeta binding were identified; and it was determined that 14-3-3zeta associated with the tuberin-hamartin complex. Finally, it was shown that the tuberin/14-3-3zeta interaction is regulated by Akt-mediated phosphorylation of tuberin, providing insight into how tuberin may regulate phosphorylation of S6.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12176984     DOI: 10.1074/jbc.M204802200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

Review 1.  14-3-3ζ as a prognostic marker and therapeutic target for cancer.

Authors:  Christopher L Neal; Dihua Yu
Journal:  Expert Opin Ther Targets       Date:  2010-12       Impact factor: 6.902

2.  Isolation and growth of smooth muscle-like cells derived from tuberous sclerosis complex-2 human renal angiomyolipoma: epidermal growth factor is the required growth factor.

Authors:  Elena Lesma; Vera Grande; Stephana Carelli; Diego Brancaccio; Maria Paola Canevini; Rosa Maria Alfano; Guido Coggi; Anna Maria Di Giulio; Alfredo Gorio
Journal:  Am J Pathol       Date:  2005-10       Impact factor: 4.307

3.  Insulin like growth factor-1-induced phosphorylation and altered distribution of tuberous sclerosis complex (TSC)1/TSC2 in C2C12 myotubes.

Authors:  Mitsunori Miyazaki; John J McCarthy; Karyn A Esser
Journal:  FEBS J       Date:  2010-05       Impact factor: 5.542

4.  Mechanism of Akt1 inhibition of breast cancer cell invasion reveals a protumorigenic role for TSC2.

Authors:  Hong Liu; Derek C Radisky; Celeste M Nelson; Hui Zhang; Jimmie E Fata; Richard A Roth; Mina J Bissell
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-07       Impact factor: 11.205

5.  REDD2 is enriched in skeletal muscle and inhibits mTOR signaling in response to leucine and stretch.

Authors:  Mitsunori Miyazaki; Karyn A Esser
Journal:  Am J Physiol Cell Physiol       Date:  2009-01-07       Impact factor: 4.249

Review 6.  The TSC1-TSC2 complex: a molecular switchboard controlling cell growth.

Authors:  Jingxiang Huang; Brendan D Manning
Journal:  Biochem J       Date:  2008-06-01       Impact factor: 3.857

Review 7.  The 14-3-3 proteins: integrators of diverse signaling cues that impact cell fate and cancer development.

Authors:  Deborah K Morrison
Journal:  Trends Cell Biol       Date:  2008-11-20       Impact factor: 20.808

8.  Hypoxia regulates TSC1/2-mTOR signaling and tumor suppression through REDD1-mediated 14-3-3 shuttling.

Authors:  Maurice Phillip DeYoung; Peter Horak; Avi Sofer; Dennis Sgroi; Leif W Ellisen
Journal:  Genes Dev       Date:  2008-01-15       Impact factor: 11.361

9.  The TSC1-TSC2 complex consists of multiple TSC1 and TSC2 subunits.

Authors:  Marianne Hoogeveen-Westerveld; Leontine van Unen; Ans van den Ouweland; Dicky Halley; Andre Hoogeveen; Mark Nellist
Journal:  BMC Biochem       Date:  2012-09-24       Impact factor: 4.059

10.  Transgenic overexpression of 14-3-3 zeta protects hippocampus against endoplasmic reticulum stress and status epilepticus in vivo.

Authors:  Gary P Brennan; Eva M Jimenez-Mateos; Ross C McKiernan; Tobias Engel; Guri Tzivion; David C Henshall
Journal:  PLoS One       Date:  2013-01-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.